AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
AGENUS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.18+0.14 (+2.32%)
Close on Oct 19, 2026
- Market cap
- $255.47M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
31.7%
14M of 45M shares
Institutional holders
102
31 new, 15 sold out
Net institutional buying
5M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Raymond Debbane | 4,533,755 | 9.99% | 13G (passive) | Jul 13, 2026 |
| RA Capital Management, L.P. | 4,344,772 | 9.90% | 13G (passive) | Jul 13, 2026 |
| BlackRock, Inc. | 2,513,893 | 6.00% | 13G (passive) | Jun 30, 2026 |
| Zydus Lifesciences Ltd | 2,133,333 | 5.90% | 13D (active) | Jan 15, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AGEN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,564,884 | 5.70% | $7.85M | +2,019,222 | 0.00% |
| Vanguard Capital Management LLC | 1,676,096 | 3.72% | $5.13M | +235,864 | 0.00% |
| Vanguard Portfolio Management LLC | 1,427,587 | 3.17% | $4.37M | +232,478 | 0.00% |
| Siren, L.L.C. | 1,064,250 | 2.36% | $3.26M | – | 0.07% |
| Geode Capital Management, LLC | 1,035,040 | 2.30% | $3.17M | +686,645 | 0.00% |
| Mackenzie Financial Corp | 714,175 | 1.59% | $2.19M | New | 0.00% |
| Goldman Sachs Group Inc | 448,383 | 1.00% | $1.37M | +416,929 | 0.00% |
| Marshall Wace, Llp | 439,621 | 0.98% | $1.35M | −248,582 | 0.00% |
| Raymond James Financial Inc | 430,078 | 0.96% | $1.32M | +190,524 | 0.00% |
| Globeflex Capital L P | 418,581 | 0.93% | $1.28M | New | 0.16% |
| State Street Corp | 412,383 | 0.92% | $1.26M | +256,200 | 0.00% |
| Man Group plc | 340,425 | 0.76% | $1.04M | +61,445 | 0.00% |
| Northern Trust Corp | 314,052 | 0.70% | $961.00K | +224,332 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 310,035 | 0.69% | $948.71K | +111,533 | 0.00% |
| Vanguard Fiduciary Trust Co | 271,614 | 0.60% | $831.14K | +71,116 | 0.00% |
| Morgan Stanley | 262,068 | 0.58% | $801.93K | −33,753 | 0.00% |
| Renaissance Technologies LLC | 228,346 | 0.51% | $698.74K | −57,300 | 0.00% |
| Panagora Asset Management Inc | 179,589 | 0.40% | $549.54K | +16,441 | 0.00% |
| Susquehanna Portfolio Strategies, LLC | 158,737 | 0.35% | $485.74K | New | 0.01% |
| Jump Financial, LLC | 103,981 | 0.23% | $318.18K | −53,219 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 102 | 14M | 31.7% | 31 / 32 | 18 / 15 | 7M | 2M |
| Q1 2026 | 87 | 9M | 20.5% | 13 / 15 | 32 / 20 | 4M | 2M |
| Q4 2025 | 96 | 10M | 22.5% | 22 / 25 | 30 / 10 | 3M | 1M |
| Q3 2025 | 87 | 9M | 19.6% | 21 / 20 | 28 / 24 | 2M | 2M |
| Q2 2025 | 91 | 9M | 19.9% | 33 / 19 | 28 / 29 | 3M | 3M |
| Q1 2025 | 88 | 9M | 19.7% | 18 / 22 | 26 / 14 | 2M | 1M |
| Q4 2024 | 84 | 8M | 18.7% | 17 / 27 | 19 / 30 | 2M | 2M |
| Q3 2024 | 97 | 8M | 18.6% | 32 / 27 | 22 / 21 | 4M | 3M |
| Q2 2024 | 88 | 9M | 19.7% | 84 / 0 | 4 / 5 | 9M | 1M |
| Q1 2024 | 10 | 1M | 2.2% | 10 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of AGEN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,159,672 | 2.58% | $3.55M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 903,711 | 2.01% | $2.77M | 0.00% | Jun 30, 2026 |
| Vanguard Strategic Equity Fund | 511,809 | 1.14% | $1.57M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 485,158 | 1.08% | $1.48M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 435,952 | 0.97% | $3.27M | 0.01% | Jul 31, 2026 |
| Vanguard Explorer Fund | 290,646 | 0.65% | $2.18M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 258,455 | 0.57% | $790.87K | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 256,842 | 0.57% | $785.94K | 0.01% | Jun 30, 2026 |
| Vanguard Strategic Small-Cap Equity Fund | 205,345 | 0.46% | $628.36K | 0.02% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 163,921 | 0.36% | $573.72K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 133,984 | 0.30% | $409.99K | 0.03% | Jun 30, 2026 |
| Small Company Growth Portfolio | 114,747 | 0.25% | $351.13K | 0.02% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 96,310 | 0.21% | $722.33K | 0.01% | Jul 31, 2026 |
| Siit Small Cap Ii Fund | 84,700 | 0.19% | $296.45K | 0.12% | May 31, 2026 |
| Master Small Cap Index Series | 74,480 | 0.17% | $227.91K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Garo H. Armen | See Remarks, Director | 402,406 | 0.89% | Aug 12, 2026 |
| Jennifer Buell | See Remarks, Director | 19,738 | 0.04% | Aug 7, 2026 |
| Steven J. O'Day | Chief Medical Officer | 57,116 | 0.13% | Aug 7, 2026 |
| Austin Charette | Principal Accounting Officer | 9,115 | 0.02% | Apr 28, 2026 |
| Christine M. Klaskin | PFO & PAO | 23,510 | 0.05% | Jun 30, 2025 |
| Marco Tullio Marcucci | Director | 5,480 | 0.01% | Sep 16, 2026 |
| Thomas L. Harrison | Director | 47,545 | 0.11% | Aug 11, 2026 |
| Brian Corvese | Director | 92,085 | 0.20% | Aug 11, 2026 |
| Susan B. Hirsch | Director | 118,725 | 0.26% | Aug 7, 2026 |
| Timothy Wright | Director | 55,391 | 0.12% | Aug 7, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Garo H. Armen See Remarks, Director | Jul 10, 2026 | Award | +4,852 | $3.35 | $16.25K | 371,108 |
| Thomas L. Harrison Director | Jul 1, 2026 | Award | +8,547 | $3.58 | $30.60K | 47,545 |
| Garo H. Armen See Remarks, Director | Jun 26, 2026 | Award | +5,364 | $3.03 | $16.25K | 366,256 |
| Garo H. Armen See Remarks, Director | Jun 12, 2026 | Award | +4,925 | $3.30 | $16.25K | 360,892 |
| Garo H. Armen See Remarks, Director | May 29, 2026 | Award | +4,644 | $3.50 | $16.25K | 355,967 |
| Garo H. Armen See Remarks, Director | May 15, 2026 | Award | +4,540 | $3.58 | $16.25K | 351,323 |
| Garo H. Armen See Remarks, Director | May 1, 2026 | Award | +4,233 | $3.84 | $16.25K | 346,783 |
| Garo H. Armen See Remarks, Director | Apr 17, 2026 | Award | +3,403 | $4.79 | $16.30K | 342,550 |
| Garo H. Armen See Remarks, Director | Apr 3, 2026 | Award | +4,629 | $3.33 | $15.41K | 339,147 |
| Thomas L. Harrison Director | Apr 1, 2026 | Award | +9,228 | $3.32 | $30.64K | 38,998 |
| Garo H. Armen See Remarks, Director | Mar 20, 2026 | Award | +3,983 | $3.71 | $14.78K | 334,518 |
| Garo H. Armen See Remarks, Director | Mar 6, 2026 | Award | +4,994 | $2.96 | $14.78K | 330,535 |
| Garo H. Armen See Remarks, Director | Feb 20, 2026 | Award | +4,829 | $3.06 | $14.78K | 325,541 |
| Garo H. Armen See Remarks, Director | Feb 6, 2026 | Award | +5,027 | $2.94 | $14.78K | 320,712 |
| Garo H. Armen See Remarks, Director | Jan 23, 2026 | Award | +4,562 | $3.24 | $14.78K | 315,685 |
| Garo H. Armen See Remarks, Director | Jan 9, 2026 | Award | +3,780 | $3.91 | $14.78K | 311,123 |
| Thomas L. Harrison Director | Jan 2, 2026 | Award | +7,691 | $3.98 | $30.61K | 29,770 |
| Garo H. Armen See Remarks, Director | Dec 26, 2025 | Award | +4,942 | $3.31 | $16.36K | 307,343 |
| Garo H. Armen See Remarks, Director | Dec 12, 2025 | Award | +4,316 | $3.79 | $16.36K | 302,401 |
| Garo H. Armen See Remarks, Director | Nov 28, 2025 | Award | +3,587 | $4.56 | $16.36K | 298,085 |
| Garo H. Armen See Remarks, Director | Nov 14, 2025 | Award | +3,769 | $4.34 | $16.36K | 294,498 |
| Garo H. Armen See Remarks, Director | Oct 31, 2025 | Award | +4,120 | $3.97 | $16.36K | 290,729 |
| Garo H. Armen See Remarks, Director | Oct 17, 2025 | Award | +4,216 | $3.88 | $16.36K | 286,609 |
| Garo H. Armen See Remarks, Director | Oct 3, 2025 | Award | +3,951 | $4.14 | $16.36K | 282,393 |
| Thomas L. Harrison Director | Oct 1, 2025 | Award | +5,780 | $5.01 | $28.96K | 22,079 |
| Garo H. Armen See Remarks, Director | Sep 19, 2025 | Award | +3,734 | $4.38 | $16.35K | 278,442 |
| Garo H. Armen See Remarks, Director | Sep 5, 2025 | Award | +3,778 | $4.33 | $16.36K | 274,708 |
| Garo H. Armen See Remarks, Director | Aug 22, 2025 | Award | +3,619 | $4.52 | $16.36K | 270,930 |
| Garo H. Armen See Remarks, Director | Aug 8, 2025 | Award | +3,407 | $4.80 | $16.35K | 267,311 |
| Garo H. Armen See Remarks, Director | Jul 25, 2025 | Award | +2,745 | $5.96 | $16.36K | 263,904 |
| Garo H. Armen See Remarks, Director | Jul 11, 2025 | Award | +2,317 | $7.06 | $16.36K | 261,159 |
| Thomas L. Harrison Director | Jul 1, 2025 | Award | +7,401 | $3.46 | $25.61K | 16,299 |
| Garo H. Armen See Remarks, Director | Jun 27, 2025 | Award | +3,436 | $4.76 | $16.36K | 258,842 |
| Steven J. O'Day Chief Medical Officer | Jun 18, 2025 | Award | +43,497 | $4.47 | $194.43K | 57,116 |
| Garo H. Armen See Remarks, Director | Jun 18, 2025 | Award | +61,397 | $4.47 | $274.44K | 255,406 |
| Christine M. Klaskin PFO & PAO | Jun 18, 2025 | Award | +15,782 | $4.47 | $70.55K | 23,478 |
| Garo H. Armen See Remarks, Director | Jun 13, 2025 | Award | +3,480 | $4.70 | $16.36K | 194,009 |
| Garo H. Armen See Remarks, Director | May 30, 2025 | Award | +4,769 | $3.43 | $16.36K | 190,529 |
| Garo H. Armen See Remarks, Director | May 16, 2025 | Award | +4,700 | $3.48 | $16.36K | 185,750 |
| Jennifer Buell Director | May 2, 2025 | Award | +581 | $3.11 | $1.81K | 19,738 |
| Garo H. Armen See Remarks, Director | May 2, 2025 | Award | +5,260 | $3.11 | $16.36K | 181,060 |
| Jennifer Buell Director | Apr 18, 2025 | Award | +869 | $2.08 | $1.81K | 19,157 |
| Garo H. Armen See Remarks, Director | Apr 18, 2025 | Award | +7,886 | $2.08 | $16.40K | 175,800 |
| Jennifer Buell Director | Apr 4, 2025 | Award | +1,159 | $1.56 | $1.81K | 18,288 |
| Garo H. Armen See Remarks, Director | Apr 4, 2025 | Award | +10,288 | $1.56 | $16.05K | 167,914 |
| Thomas L. Harrison Director | Apr 1, 2025 | Award | +8,898 | $2.88 | $25.63K | 8,898 |
| Jennifer Buell Director | Mar 21, 2025 | Award | +1,123 | $1.61 | $1.81K | 17,129 |
| Garo H. Armen See Remarks, Director | Mar 21, 2025 | Award | +9,243 | $1.61 | $14.88K | 157,626 |
| Jennifer Buell Director | Mar 7, 2025 | Award | +409 | $2.35 | $961 | 15,646 |
| Garo H. Armen See Remarks, Director | Mar 7, 2025 | Award | +6,332 | $2.35 | $14.88K | 148,383 |
| Jennifer Buell Director | Feb 21, 2025 | Award | +545 | $3.32 | $1.81K | 15,237 |
| Jennifer Buell Director | Feb 21, 2025 | Award | +626 | $3.32 | $2.08K | 15,318 |
| Garo H. Armen See Remarks, Director | Feb 21, 2025 | Award | +4,483 | $3.32 | $14.88K | 142,051 |
| Jennifer Buell Director | Feb 7, 2025 | Award | +516 | $3.50 | $1.81K | 14,692 |
| Garo H. Armen See Remarks, Director | Feb 7, 2025 | Award | +4,251 | $3.50 | $14.88K | 137,568 |
| Jennifer Buell Director | Jan 24, 2025 | Tax withholding | −270 | $3.57 | $964 | 14,176 |
| Garo H. Armen See Remarks, Director | Jan 24, 2025 | Award | +4,169 | $3.57 | $14.88K | 133,317 |
| Jennifer Buell Director | Jan 24, 2025 | Award | +776 | $3.57 | $2.77K | 14,446 |
| Garo H. Armen See Remarks, Director | Jan 10, 2025 | Award | +4,777 | $3.12 | $14.90K | 129,148 |
| Garo H. Armen See Remarks, Director | Dec 27, 2024 | Award | +5,931 | $2.75 | $16.31K | 124,371 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.